Every open market buy and sale of Stoke Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $7.9M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when STOK insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an STOK officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every STOK insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Barry TichoChief Medical Officer | Sale plan | 7,195 | $26.39 | $190K | 11,864 | Nov 4Form 4 |
| Oct 2, 2026 | Jonathan AllanGeneral Counsel & Corp Sec | Sale plan | 627 | $26.33 | $17K | 20,598 | Oct 2Form 4 |
| Oct 1, 2026 | Barry TichoChief Medical Officer | Sale plan | 1,051 | $26.16 | $27K | 19,059 | Oct 2Form 4 |
| Sep 1, 2026 | Barry TichoChief Medical Officer | Sale plan | 5,545 | $30.67 | $170K | 20,110 | Sep 3Form 4 |
| Aug 18, 2026 | Edward M. Kaye MDDirector | Sale | 12,567 | $32.03 | $403K | 124,557 | Aug 18Form 4 |
| Aug 18, 2026 | Barry TichoChief Medical Officer | Sale | 4,767 | $32.03 | $153K | 25,655 | Aug 18Form 4 |
| Aug 18, 2026 | Jonathan AllanGeneral Counsel & Corp Sec | Sale | 2,861 | $32.03 | $92K | 21,225 | Aug 18Form 4 |
| Aug 3, 2026 | Barry TichoChief Medical Officer | Sale plan | 7,176 | $29.04 | $208K | 20,422 | Aug 5Form 4 |
| Jul 1, 2026 | Barry TichoChief Medical Officer | Sale plan | 7,228 | $32.66 | $236K | 27,598 | Jul 6Form 4 |
| Jun 16, 2026 | Jonathan AllanGeneral Counsel & Corp Sec | Sale plan | 1,457 | $29.95 | $44K | 18,086 | Jun 18Form 4 |
| Jun 1, 2026 | Barry TichoChief Medical Officer | Sale plan | 1,795 | $30.58 | $55K | 34,826 | Jun 3Form 4 |
| May 1, 2026 | Barry TichoChief Medical Officer | Sale plan | 2,243 | $32.79 | $74K | 36,621 | May 5Form 4 |
| Apr 1, 2026 | Barry TichoChief Medical Officer | Sale plan | 1,838 | $32.66 | $60K | 38,864 | Apr 3Form 4 |
| Mar 20, 2026 | Jonathan AllanGeneral Counsel & Corp Sec | Sale plan | 9,293 | $33.69 | $313K | 19,543 | Mar 24Form 4 |
| Mar 19, 2026 | Barry TichoChief Medical Officer | Sale plan | 14,311 | $31.92 | $457K | 40,702 | Mar 19Form 4 |
STOK insider trading FAQ
Are STOK insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of STOK on the open market in 0 trades, and 8 sold $7.9M in 31 trades, 81% of that under pre-arranged trading plans.
When did an STOK insider last buy shares?
There has been no open market insider purchase of STOK in the last two years.
When did an STOK insider last sell shares?
Barry Ticho (Chief Medical Officer) sold 7,195 shares for $190K on Nov 2, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
